TEVA GROUP Trademark

Trademark Overview


On Friday, November 22, 2002, a trademark application was filed for TEVA GROUP with the United States Patent and Trademark Office. The USPTO has given the TEVA GROUP trademark a serial number of 78188060. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 6, 2015. This trademark is owned by Teva Pharmaceutical Industries Ltd.. The TEVA GROUP trademark is filed in the Pharmaceutical Products category with the following description:

House mark for a full line of pharmaceutical preparations, veterinary preparations and pharmaceutical active ingredients

General Information


Serial Number78188060
Word MarkTEVA GROUP
Filing DateFriday, November 22, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 6, 2015
Registration Number2937656
Registration DateTuesday, April 5, 2005
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 11, 2005

Trademark Statements


Disclaimer with Predetermined Text"GROUP"
Goods and ServicesHouse mark for a full line of pharmaceutical preparations, veterinary preparations and pharmaceutical active ingredients
Translation of Words in MarkTHE ENGLISH TRANSLATION OF TEVA IS NATURE.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 6, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTeva Pharmaceutical Industries Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressJerusalem 91010
IL

Party NameTeva Pharmaceutical Industries Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressJerusalem 91010
IL

Party NameTeva Pharmaceutical Industries Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressJerusalem 91010
IL

Trademark Events


Event DateEvent Description
Friday, November 6, 2015CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Monday, June 1, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 1, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, March 26, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, March 23, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 18, 2011TEAS SECTION 8 & 15 RECEIVED
Wednesday, December 1, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 1, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 5, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 5, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 10, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 10, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 5, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, January 11, 2005PUBLISHED FOR OPPOSITION
Wednesday, December 22, 2004NOTICE OF PUBLICATION
Thursday, November 4, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 29, 2004ASSIGNED TO LIE
Tuesday, October 19, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 23, 2004AMENDMENT FROM APPLICANT ENTERED
Monday, August 30, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 30, 2004PAPER RECEIVED
Monday, March 1, 2004UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Monday, March 1, 2004PAPER RECEIVED
Monday, March 1, 2004NON-FINAL ACTION MAILED
Thursday, January 15, 2004ASSIGNED TO EXAMINER
Thursday, December 4, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 8, 2003PAPER RECEIVED
Thursday, June 5, 2003NON-FINAL ACTION MAILED
Tuesday, May 20, 2003ASSIGNED TO EXAMINER
Monday, February 3, 2003PAPER RECEIVED